Impact of 18F-FDG PET on the management of recurrent breast cancer: a meta-analysis

[1]  Se Kyung Lee,et al.  Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry , 2020, Journal of breast cancer.

[2]  Amy M. Sitapati,et al.  Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[4]  Cheng-Li Lin,et al.  Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis. , 2018, European journal of radiology.

[5]  S. Morbelli,et al.  Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence , 2017, Breast cancer.

[6]  M. Koizumi,et al.  Impact of FDG-PET findings on decisions regarding patient management strategies: a multicenter trial in patients with lung cancer and other types of cancer , 2015, Annals of Nuclear Medicine.

[7]  Ren-Shyan Liu,et al.  Role of 2-[18F] Fluoro-2-Deoxy-D-Glucose-Positron Emission Tomography/Computed Tomography in the Post-Therapy Surveillance of Breast Cancer , 2014, PloS one.

[8]  R. Hicks,et al.  The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification , 2014, Cancer Imaging.

[9]  D. Zidan,et al.  Postoperative restaging: PET/CT impact on diagnosis and management , 2013 .

[10]  D. Rubello,et al.  Indeterminate pulmonary nodules on CT images in breast cancer patient: The additional value of 18F‐FDG PET/CT , 2012, Journal of medical imaging and radiation oncology.

[11]  A. Bhattacharya,et al.  Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma , 2012, Nuclear medicine communications.

[12]  D. Rubello,et al.  Tumor Marker–Guided PET in Breast Cancer Patients—A Recipe for a Perfect Wedding: A Systematic Literature Review and Meta-Analysis , 2012, Clinical nuclear medicine.

[13]  E. Brain,et al.  Breast cancer recurrence diagnosis suspected on tumor marker rising , 2011, Cancer.

[14]  S. Ahn,et al.  The 70-Gene Prognostic Signature for Korean Breast Cancer Patients , 2011, Journal of breast cancer.

[15]  E. Georgiou,et al.  The impact of FDG-PET/CT on the management of breast cancer patients with elevated tumor markers and negative or equivocal conventional imaging modalities , 2011, Nuclear medicine communications.

[16]  J. Wesseling,et al.  The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[17]  Ora Israel,et al.  The role of FDG‐PET/CT in suspected recurrence of breast cancer , 2006, Cancer.

[18]  G. Houvenaeghel,et al.  Computed tomography in suspected local breast cancer recurrence , 2006, Breast Cancer Research and Treatment.

[19]  M. Blaufox,et al.  A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases , 2005, Breast Cancer Research and Treatment.

[20]  J. Talbot,et al.  [18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[22]  Hans-Jürgen Gallowitsch,et al.  F-18 Fluorodeoxyglucose Positron-Emission Tomography in the Diagnosis of Tumor Recurrence and Metastases in the Follow-Up of Patients With Breast Carcinoma: A Comparison to Conventional Imaging , 2003, Investigative radiology.

[23]  A. Ellis.  Breast , 2002, BMJ : British Medical Journal.

[24]  D. Noh,et al.  Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer , 2001, World Journal of Surgery.

[25]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[26]  J. Tukey,et al.  Transformations Related to the Angular and the Square Root , 1950 .

[27]  K. Pritchard,et al.  F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer , 2015 .

[28]  S. Schoenberg,et al.  Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. , 2008, European journal of radiology.

[29]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.